A slew of recently introduced bills aim to restrict how retailers use consumer data to influence pricing decisions and even ban the adoption of electronic shelf labels.

Many platforms used by investigators were never designed with clinical trials in mind. The consequence is a widening infrastructure gap that leaves independent investigators operating complicated ...